Format

Send to

Choose Destination
Bull Acad Natl Med. 2011 Apr-May;195(4-5):1005-13; discussion 1013-4.

[Ten years' experience of preimplantation genetic diagnosis in Paris: remaining obstacles and potential solutions].

[Article in French]

Author information

1
Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, Clamart. Univ. Paris-Sud, Clamart, INSERM, U782, Clamart, F-92140. rene.frydman@abc.aphp.fr

Abstract

Preimplantation genetic diagnosis (PGD) has been authorized in France since 1999. Encouraging results have been obtained during the past 10 years in our Paris center, where 832 patients have undergone 1056 IVF-PGD procedures. With the advent of new techniques for the identification of genetic disease markers, our center can now offer PGD procedures for aneuploidy and 75 single-gene diseases. New indications for PGD have also been developed, such as mitochondrial DNA diseases, amyloid neuropathy, pulmonary arterial hypertension, and HLA typing The implantation rate is currently 29,6% and, by 31 December 2009, 151 healthy babies had been born. Unfortunately, demand for PGD procedures far outstrips available technical capacity, and the waiting period is longer than 18 months. Increased funding is urgently needed.

PMID:
22375366
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center